ATE210149T1 - Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden - Google Patents

Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden

Info

Publication number
ATE210149T1
ATE210149T1 AT94919428T AT94919428T ATE210149T1 AT E210149 T1 ATE210149 T1 AT E210149T1 AT 94919428 T AT94919428 T AT 94919428T AT 94919428 T AT94919428 T AT 94919428T AT E210149 T1 ATE210149 T1 AT E210149T1
Authority
AT
Austria
Prior art keywords
dynorphine
tyr
analogues
des
inflammatory composition
Prior art date
Application number
AT94919428T
Other languages
English (en)
Inventor
Edward T Wei
Holly A Thomas
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE210149T1 publication Critical patent/ATE210149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94919428T 1993-06-09 1994-06-09 Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden ATE210149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/074,210 US5482930A (en) 1993-06-09 1993-06-09 Anti-inflammatory composition and method with des-Tyr dynorphin and analogues
PCT/US1994/006502 WO1994029337A1 (en) 1993-06-09 1994-06-09 Anti-inflammatory composition and method with des-tyr dynorphin and analogues

Publications (1)

Publication Number Publication Date
ATE210149T1 true ATE210149T1 (de) 2001-12-15

Family

ID=22118342

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919428T ATE210149T1 (de) 1993-06-09 1994-06-09 Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden

Country Status (8)

Country Link
US (1) US5482930A (de)
EP (1) EP0751954B1 (de)
JP (1) JPH08511541A (de)
AT (1) ATE210149T1 (de)
AU (1) AU679241B2 (de)
CA (1) CA2164880A1 (de)
DE (1) DE69429365D1 (de)
WO (1) WO1994029337A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE276272T1 (de) * 1993-06-18 2004-10-15 Curative Tech Inc Entzündungshemmende peptide
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US20060025348A1 (en) * 1997-05-28 2006-02-02 Pilon Aprile L Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US6437092B1 (en) 1998-11-06 2002-08-20 Conjuchem, Inc. Conjugates of opioids and endogenous carriers
US6228840B1 (en) 1998-02-27 2001-05-08 Edward T. Wei Melanocortin receptor antagonists and modulations of melanocortin receptor activity
DE60003011T2 (de) * 1999-03-26 2004-04-08 Regeneron Pharmaceuticals, Inc. Modulierung der gefässepermeabilität mittels tie2 rezeptoraktivatoren
US6706892B1 (en) 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
WO2002089845A1 (en) * 2001-05-08 2002-11-14 Toray Industries, Inc. Remedies for sepsis
US20050143300A1 (en) * 2003-10-10 2005-06-30 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050250694A1 (en) * 2003-10-10 2005-11-10 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050130897A1 (en) * 2003-12-11 2005-06-16 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
EP1750711B1 (de) 2004-05-12 2016-10-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Behandlung von entzündlichen erkrankungen mit morphinan
AU2011265315B2 (en) * 2004-05-12 2014-08-28 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
NZ588895A (en) 2008-05-13 2012-07-27 Clarassance Inc Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis
CA2813740C (en) 2009-10-15 2016-08-02 Clarassance, Inc. Recombinant human cc10 protein for treatment of influenza
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
CN116970034A (zh) * 2022-10-14 2023-10-31 深圳市维琪科技股份有限公司 合成肽及其组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4361553A (en) * 1981-05-18 1982-11-30 Regents Of The University Of California Therapeutic uses of dynorphin
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4684624A (en) * 1983-12-22 1987-08-04 Yoshio Hosobuchi Method of treating cerebral ischemia
US4801612A (en) * 1986-07-03 1989-01-31 Regents Of The University Of California Method of inhibiting inflammatory response
US5177060A (en) * 1990-01-09 1993-01-05 Regents Of The University Of California Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
WO1993025217A1 (en) * 1992-06-12 1993-12-23 Des-Tyr Dynorphin Partnership Des-tyr dynorphin analogues

Also Published As

Publication number Publication date
AU679241B2 (en) 1997-06-26
US5482930A (en) 1996-01-09
EP0751954A4 (de) 1998-06-03
WO1994029337A1 (en) 1994-12-22
JPH08511541A (ja) 1996-12-03
CA2164880A1 (en) 1994-12-22
EP0751954A1 (de) 1997-01-08
DE69429365D1 (de) 2002-01-17
EP0751954B1 (de) 2001-12-05
AU7058394A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
DE69417252D1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
AU3742895A (en) Novel compositions
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
IL138665A0 (en) Peptide factor
CA2284482A1 (en) Treatment of cardiomyopathy
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
FR2662698B1 (de)
AU1384995A (en) Human circulating cytokine cc-1
CA2197544A1 (en) Fungicidal composition comprising metalaxyl and fludioxonil
WO1996030042A3 (en) Methods of treating inflammation and compositions therefor
CA2294607A1 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
MY123805A (en) Stabilized pharmaceutical composition based on quinupristine and dalfopristine and their preparation.
MX22991A (es) Agente edulcorante derivado del acido l-aspartico o l-glutamico y el procedimiento para su preparacion.
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
JPS6463342A (en) Stabilization of glutathione-containing composition
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV
EP0789031A3 (de)
Danielewski Computer simulation of corrosion processes, contemporary patterns of mass transport processes
JPS5758630A (en) Interferon inducer
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці
RU96100906A (ru) Способ радикального лечения первичного гипотиреоза

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties